Invited Speaker Presentation-TP53 alterations in myelodysplastic neoplasms & acute myeloid leukemia
27:49
Spotlight Symposium: GOAL Consortium
1:14:27
Major Treatment Decisions for Patients with Acute Myeloid Leukemia (AML)
1:04:42
Clonal Hematopoiesis: Origins and Clinical Implications
51:02
25. Cancer 1
1:52:03
Novel targeted therapies for Acute Myeloid Leukemia
20:35
Jurjen Versluis: Transplant for high-risk MDS | #18 | Trainee Pearls
51:44
Flow cytometry in Chronic Myeloid Neoplasms: Current Recommendations and Challenges
32:32